Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
International Journal of Urology : Official Journal of the Japanese Urological Association|September 19, 2022
miRNAs in prostate cancer: Intercellular and extracellular communicationsFumihiko Urabe, Yusuke Yamamoto, Takahiro Kimura
Clinical Calcium|December 28, 2017
[The biological role of exosomes in bone remodeling and bone diseases.]Fumihiko Urabe, Yusuke Yoshioka, Takahiro Ochiya
Frontiers in Oncology|April 27, 2026
Circulating tumor DNA as a prognostic and monitoring biomarker in urothelial cancersJeanny B Aragon-Ching, Fumihiko Urabe, Shugo Yajima
STAR Protocols|January 16, 2025
Protocol for extracellular vesicle secretion-related gene screening via ExoScreen techniqueTomofumi Yamamoto, Fumihiko Urabe, Yusuke Yoshioka, et al.
Lasers in Surgery and Medicine|September 3, 2025
Vaginal Laser Therapy as a Potential Treatment Option for Postmenopausal Women With Recurrent Cystitis: Initial Experience From a Single InstitutionHirokazu Abe, Fumihiko Urabe, Minoru Nakazono, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 5, 2018
Extracellular vesicles: Toward a clinical application in urological cancer treatmentFumihiko Urabe, Nobuyoshi Kosaka, Takahiro Kimura, et al.
Current Opinion in Urology|June 5, 2024
Extracellular vesicles as novel uro-oncology biomarkers: insights toward clinical applicationsFumihiko Urabe, Takaaki Tamura, Shinichi Sakamoto, et al.
Clinical and Translational Medicine|December 15, 2017
The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatmentFumihiko Urabe, Nobuyoshi Kosaka, Yusuke Yoshioka, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectivesKentaro Yoshihara, Kagenori Ito, Takahiro Kimura, et al.
International Cancer Conference Journal|July 23, 2026
Complete response after enfortumab vedotin plus pembrolizumab for a contralateral ureteral tumor in a solitary kidney after nephroureterectomyMasataka Kubo, Fumihiko Urabe, Kosuke Iwatani, et al.
Pageof 22